This content is for Raper Capital Pro subscribers only.
To gain access, please subscribe HERE.
This content is for Raper Capital Pro subscribers only.
To gain access, please subscribe HERE.
This content is for Raper Capital Pro subscribers only.
To gain access, please subscribe HERE.
A month ago I broke down the Nio/Hefei transaction that purported to put a high valuation on Nio's China business, suggesting that US investors and bondholders were probably being fleeced. With the release of Nio's 20-F annual filing, we can now definitively conclude that the Hefei 'Strategic Transaction' is nothing more than an asset strip, … Continue reading More on NIO: the devil is in the details
This content is for Raper Capital Pro subscribers only.
To gain access, please subscribe HERE.
This content is for Raper Capital Pro subscribers only.
To gain access, please subscribe HERE.
This content is for Raper Capital Pro subscribers only.
To gain access, please subscribe HERE.
Thesis summary: Metlifecare (MET), a New Zealand-listed retirement village operator, is a highly attractive, 'heads I win big, tails I don't lose' type of investment. EQT, the Swedish private equity powerhouse, is attempting to reneg on a recently-agreed takeover of MET at $7/share - a 68% premium to the current quote ($4.16) - by claiming the onset … Continue reading Metlifecare: heads I win big, tails I don’t lose (or better)